Neurogene Therapeutics
  • ABOUT US
    • About Neurogene
    • Core Values
    • Leadership Team
  • OUR PIPELINE
    • Partnerships
    • Clinical Trials
  • OUR TECHNOLOGY
    • EXACT Technology
    • Manufacturing
  • PATIENTS AND FAMILIES
    • Patient Advocacy & Engagement Team
    • Our Approach
    • Clinical Programs and Resources
  • EXPANDED ACCESS POLICY
  • CAREERS
  • NEWS
  • CONTACT US
  • TWITTER
  • LINKEDIN
  • FACEBOOK

Focusing on the Future of Life-Changing Genetic Medicines

Gene therapy holds incredible promise to revolutionize medical treatment. At Neurogene we believe that innovation, robust scientific execution, and a strong sense of purpose are required to turn this promise into reality. Our focus is to develop life-changing genetic medicines for people and their families impacted by devastating neurological diseases.

Learn More >>

OUR PIPELINE

We are building a gene therapy pipeline to help address the high unmet need for rare neurological diseases.

LEARN MORE

ABOUT US

At Neurogene, we are driven by a strong sense of purpose to advance genetic medicines.

LEARN MORE

LATEST NEWS

Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome

Two pediatric patients with Rett syndrome dosed in the United States with NGN-401, Neurogene’s lead gene therapy product candidate leveraging…

Learn More

State of the Art Manufacturing

Neurogene owns and operates a state-of-the-art gene therapy manufacturing facility in Houston, Texas with fully integrated process and analytical development, and CGMP capabilities. We have developed two scalable AAV manufacturing processes (mammalian and insect cell-based production) to support preclinical studies and clinical trials.

LEARN MORE

Neurogene Inc.

Corporate Headquarters
535 W 24th Street, 5th Floor
New York, NY 10011

Manufacturing Headquarters
Houston, TX 77025
 

© 2023 Neurogene Inc.
GL-GEN-WEB-0002v8

Translation Disclaimer
  • Privacy
  • Terms of Use